A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease
Status:
Completed
Trial end date:
2020-01-09
Target enrollment:
Participant gender:
Summary
The objective of the study is to assess the safety, efficacy, optimum dosage, and dosing
regimen of K-161 in adult subjects with moderate to severe dry eye disease.